craniofacial
• at E13.5
|
• at P8 and P11
|
• at P2
|
• at P8 and P11
|
• at P8 and P11
|
• at P2
|
• at P8 and P11
|
• at P8
|
• in around 18% of surviving mice at age 6 weeks
|
• in around 18% of surviving mice at age 6 weeks
|
malocclusion
(
J:164801
)
• in around 18% of surviving mice at age 6 weeks
|
• at P2
|
• at P2
|
• at P2
|
skeleton
• at E13.5
|
• at P8 and P11
|
• at P2
|
• at P8 and P11
|
• at P8 and P11
|
• at P2
|
• at P8 and P11
|
• at P8
|
• in around 18% of surviving mice at age 6 weeks
|
• in around 18% of surviving mice at age 6 weeks
|
malocclusion
(
J:164801
)
• in around 18% of surviving mice at age 6 weeks
|
• at P2
|
• at P2
|
• at P8 and P11
|
growth/size/body
• in around 18% of surviving mice at age 6 weeks
|
• in around 18% of surviving mice at age 6 weeks
|
malocclusion
(
J:164801
)
• in around 18% of surviving mice at age 6 weeks
|
• at P2
|
• at P2
|
microcephaly
(
J:164801
)
• severe reduction at E13.5
|
• severe runting at E13.5
|
• at age 3 months
|
mortality/aging
• reduced Mendelian ratio suggests 30% survival rate on postnatal day 21 (P21)
|
• reduced Mendelian ratio suggests 62% survival rate on neonatal day 1 (P1)
|
nervous system
• at E13.5
|
digestive/alimentary system
• at P2
|
• at P2
|
vision/eye
• at E13.5
|